The U.S. has launched an investigation into Germany’s pharma policies over what it referred to as “persistent underpayment” for medicines as the European country looks to limit spiraling healthcare costs, including spending on drugs. “President Trump has made clear that American patients should not be shouldering a disproportionate share of global pharmaceutical research and development,”…
Public markets are beginning to reopen for biotech companies after several years of muted activity. But the strongest companies may still be more likely to sell themselves to Big Pharma rather than testing investor appetite in an IPO, according to JPMorgan’s top healthcare dealmakers. The IPO window has reopened for high-quality biotech companies, but investors…
A photo shows a poster depicting U.S. President Donald Trump, Russian President Vladimir Putin and Chinese President Xi Jinping and reading “Breaking with Europe now of all times? NO on the SVP-Chaos-Initiative” in Thayngen, northern Switzerland, on June 1, 2026. Sebastien Bozon | Afp | Getty Images Switzerland, a wealthy country that has historically embraced…
Novartis‘ CEO warned Tuesday that the U.S. drug pricing policy under President Donald Trump poses a “very difficult situation” and the reality will soon catch up with both drugmakers and patients. “The longer-term implications are significant,” CEO Vas Narasimhan told CNBC’s Carolin Roth. Novartis is focused on getting European and Japanese governments to quickly change…
LONDON — European stocks are expected to open higher on Tuesday as investors await Washington’s response to Iranian peace proposals and look ahead to earnings reports from several regional companies. The U.K.’s FTSE 100 index is seen opening a touch higher, with Germany’s DAX up 0.23%, France’s CAC 40 up 0.34% and Italy’s FTSE MIB 0.3%…
Pharma thinks it’s found the next frontier in preventing heart attacks. Novartis, Amgen and Eli Lilly are among the drugmakers betting that slashing levels of a particularly bad form of cholesterol could deliver the next blockbusters in cardiology. All three of the pharmaceutical giants are in late-stage trials to test whether drugs that cut Lp(a)…
A year after President Donald Trump declared his “liberation day” and imposed sweeping tariffs on imports, kicking off a wave of economic and political uncertainty, some companies are still feeling the effects. While some industries have emerged largely unscathed — having weathered twists and turns of several tariff iterations — others, such as retail, automotive,…
President Donald Trump makes an announcement from the Oval Office at the White House in Washington, Nov. 6, 2025. Jonathan Ernst | Reuters President Donald Trump on Thursday announced the launch of TrumpRx — a direct-to-consumer website that is key to his administration’s efforts to lower prescription drug costs in the U.S. The president said…
U.S. President Donald Trump speaks to members of the press before boarding Marine One on the South Lawn of the White House on Jan. 16, 2026 in Washington, DC. Tom Brenner | Getty Images U.S. President Donald Trump has threatened a rising wave of tariffs on several European allies, raising the alarm for industries and…
We get so caught up in the buzz and the sizzle that we forget about the steak, especially in this era of GLP-1s, which have revolutionized the treatment of diabetes and obesity and are being studied for so many more diseases and conditions. That’s my chief takeaway from meeting with 15 different CEOs, a dozen…
